In contrast, treatment with CD47 mAb InhibRx increased phagocytosis by ~20–25% for all of the MCL cell lines (Figure 2H), with all cell lines having consistently high expression of CD47 and no correlation between expression and phagocytosis being detected (Supplementary Figure S2C,D). This evidence concerns the gene CD47 and mantle cell lymphoma.